Search Results 271-280 of 16735 for alt

1. PORtopulmonary Hypertension Treatment WIth MaCitentan ─ A RandOmized Clinical Trial

   ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

2. A Study of Lacosamide to Treat Neonatal Seizures - Mayo Clinic

   ... (ALT), and alkaline phosphatase (ALP), with the following exception: For participants with perinatal asphyxia, elevation of AST, ALT, or ALP 2mg/dL.

3. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

   AST/ALT (SGOT/SGPT) < 2.5 x ULN for the reference laboratory or < 5 x ULN in the presence of liver metastases; Serum creatinine < 1.5 x ULN. No 'active' CNS ...

4. A Study to Establish an Alcoholic Hepatitis Network - Mayo Clinic

   ALT: >40 IU/mL. Based on the judgment of the investigator, subject is not capable of complying with the study requirements. Participating Mayo Clinic ...

5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease - Mayo Clinic

   AST and ALT must be < 2.5 x ULN for the lab. Adequate renal function within 28 days before study entry defined as serum creatinine ≤ 1.5 x ULN for the lab ...

6. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

   ALT > 1.5 × upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E ...

7. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Serum AST and/or ALT > 3 times the upper limit of normal range'; Pregnancy (including family planning) or breastfeeding. Any circumstances or conditions ...

8. A Study to Investigate the Effectiveness and Safety of Efgartigimod Ph20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy - Mayo Clinic

   ... (ALT), based on central laboratory results; Electromyography demonstrating active disease within the past 3 months; Active dermatomyositis (DM) skin rash ...

9. Nedosiran In Pediatric Patients From Birth To 5 Years Of Age With PH And Relatively Intact Renal Function - Mayo Clinic

   Liver function test (LFT) abnormalities: ALT and/or AST > 1.5 × ULN for age and gender. Known hypersensitivity to nedosiran, or any of its ingredients ...

10. Itraconazole Therapy In Bronchiectasis With Airway Mold - Mayo Clinic

    Abnormal baseline liver function tests (ALT, AST, alkaline phosphatase, or bilirubin >upper limit of normal). Prolonged QTc interval on baseline ECG (>460 ms ...